NYSE:TMOLife Sciences
Thermo Fisher Scientific (TMO) Climbed, So What Is Behind The Fresh Attention?
Thermo Fisher Scientific (TMO) drew fresh attention after reporting quarterly revenue and earnings that exceeded analyst expectations, alongside completing a large Parkinson's proteomics project with The Michael J. Fox Foundation.
See our latest analysis for Thermo Fisher Scientific.
Thermo Fisher Scientific's recent earnings beat and the completion of the Parkinson's proteomics project have coincided with strong momentum, including a 16.6% 30 day share price return and a 24.5% 1 year total...